Names new chief medical officer, Anant Vinjamoori
HIMS has announced the appointment of Dr Anant Vinjamoori as chief medical officer of the Hims brand. He has a dual background in internal medicine and primary care and in longevity medicine, with more than 10 years of clinical and executive experience. He previously led the product and medical teams at Virta Health and Modern Age.
Read more
His remit covers sexual health, hormone health, dermatology, weight loss, mental health, longevity medicine and peptide therapies.
Investment thesis
Management is using this appointment to give substantive backing to the longevity-care platform narrative. Vinjamoori brings clinical skills in preventive medicine and product experience at health-tech companies, which fits HIMS's shift from telehealth towards preventive health management. Peptide therapies are written into the job responsibilities in the official press release, which shows peptides are now part of the company's formal strategic planning and not just an investor narrative.
Market data
- Analyst coverage
15
- Consensus target
28.7
- 100-day MA
23.76
- 20-day MA
25.36
- 50-day MA
24.59
- Price
29.5
- Price change (%)
7.8
- Resistance
30.5
- Weekly change (%)
5.0
A brief is a lead for our research, not a verified conclusion or advice.